Inhibikase Therapeutics, Inc. Contracts & Agreements

88 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Settlement Agreement, dated as of September 30, 2024
Settlement Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Director Offer Letter
Inhibikase Therapeutics, Inc.
2024
Form of Support Agreement
Inhibikase Therapeutics, Inc.
2024
Form of Registration Rights Agreement
Registration Rights Agreements
Inhibikase Therapeutics, Inc.
2024
Securities Purchase Agreement, dated as of October 9, 2024
Purchase Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Series B-1 Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Series A-1 Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Lock-Up Agreement (May 2024)
Inhibikase Therapeutics, Inc.
2024
Support Agreement, dated as of May 20, 2024, by and between the Company and Milton H. Werner, Ph.D
Inhibikase Therapeutics, Inc.
2024
Inducement Letter, dated as of May 20, 2024
Inhibikase Therapeutics, Inc.
2024
Placement Agency Agreement, dated as of May 20, 2024
Agency Agreements
Inhibikase Therapeutics, Inc.
2024
Securities Purchase Agreement, dated as of May 20, 2024
Purchase Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Warrant Amendment
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Series D Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Series C Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Series B Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Series A Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Common Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Placement Agency Agreement
Agency Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Warrant Agency Agreement
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Securities Purchase Agreement
Purchase Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Securities Purchase Agreement
Purchase Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Placement Agent Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Common Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2024
Form of Placement Agency Agreement
Agency Agreements
Inhibikase Therapeutics, Inc.
2024
Employment Agreement between Inhibikase Therapeutics, Inc. and Garth Lees-Rolfe, dated as of April 1, 2024
Employment Agreements
Inhibikase Therapeutics, Inc.
2024
At The Market Offering Agreement, dated February 1, 2024, by and between Inhibikase Therapeutics, Inc. and H.C. Wainwright & Co., LLC
Inhibikase Therapeutics, Inc.
2024
Registration Rights Agreement, dated as of January 25, 2023 (PIPE)
Registration Rights Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Form of Pre-Funded Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Form of Private Common Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Form of PIPE Pre-Funded Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2023
Form of PIPE Common Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Form of Placement Agent Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Securities Purchase Agreement, dated as of January 25, 2023 (Registered Direct)
Purchase Agreements
Inhibikase Therapeutics, Inc.
2023
Securities Purchase Agreement, dated as of January 25, 2023 (PIPE)
Purchase Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2023
Form of Director Offer Letter
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2022
Equity Distribution Agreement, dated May 16, 2022, by and between Inhibikase Therapeutics, Inc. and Piper Sandler & Co
Equity Distribution Agreements
Inhibikase Therapeutics, Inc.
2022
Amendment dated March 3, 2021 to the Employment Agreement, by and between Inhibikase Therapeutics, Inc. and Milton H. Werner, Ph.D., dated December 28, 2020
Employment Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2022
Amendment dated March 3, 2021 to the Employment Agreement, by and between Inhibikase Therapeutics, Inc. and Joseph Frattaroli, dated October 24, 2018
Employment Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2022
Form of Stock Option Grant Notice and Award Agreement
Stock Agreements
Inhibikase Therapeutics, Inc.
2022
Form of Representatives Warrant Agreement
Warrant Agreements
Inhibikase Therapeutics, Inc.
2021
Underwriting Agreement dated June 15, 2021 by and between Inhibikase Therapeutics, Inc. and ThinkEquity, a division of Fordham Financial Management, Inc., as representative of the...
Underwriting Agreements
Inhibikase Therapeutics, Inc.
2021
Form of Representatives Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2021
Form of Underwriting Agreement
Underwriting Agreements
Inhibikase Therapeutics, Inc.
2021
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Inhibikase Therapeutics, Inc.
Biotechnology
2021
2020 Equity Incentive Plan and forms of agreements thereunder
Bonus & Incentive Agreements
Inhibikase Therapeutics, Inc.
2020
2020 Equity Incentive Plan and forms of agreements thereunder
Bonus & Incentive Agreements
Inhibikase Therapeutics, Inc.
2020
Amendment to Promissory Note by and between Inhibikase Therapeutics, Inc. and Flagship Consulting, Inc., dated October
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2020
Warrant, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated August 25, 2020
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2020
Warrant, issued by Inhibikase Therapeutics, Inc. to Francis E. McDaniel, dated January 1, 2019
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2020
Restated Agreement to Repay Individual Loan, by and between Inhibikase Therapeutics Inc. and Milton H. Werner, Ph.D., dated June 13, 2020
Loan Agreements
Inhibikase Therapeutics, Inc.
2020
Warrant, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated August 25, 2020
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2020
Amended and Restated Second Convertible Revolving Demand Promissory 2020 Note, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated August 31, 2020
Note Agreements
Inhibikase Therapeutics, Inc.
2020
Letter Agreement to Restated Agreement to Repay Individual Loan, by and between Inhibikase Therapeutics, Inc. and Milton H. Werner, dated September 11, 2020
Loan Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2020
Convertible Revolving Demand Promissory Note, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting Inc., dated April 3, 2018
Note Agreements
Inhibikase Therapeutics, Inc.
2020
Agreement to Repay Individual Loan, by and between Inhibikase Therapeutics, Inc. and Milton H. Werner, dated February 5, 2020
Loan Agreements
Inhibikase Therapeutics, Inc.
2020
2020 Equity Incentive Plan and forms of agreements thereunder
Bonus & Incentive Agreements
Inhibikase Therapeutics, Inc.
2020
Consulting Agreement, by and between Inhibikase Therapeutics Inc. and Flagship Consulting, Inc., dated April 1, 2018
Consulting Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Collaborative Research and Development Agreement, by and between Inhibikase Therapeutics, Inc. and Sphaera Pharma Pte. Ltd., dated February 29, 2012
Development Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2020
License Agreement, by and between Inhibikase Therapeutics, Inc. and Emory University, dated June 8, 2010
License Agreements
Inhibikase Therapeutics, Inc.
2020
Fifth Restatement and Amendment to Promissory Note, issued by Inhibikase Therapeutics, Inc. to McDaniel Law Firm, PC, dated June 30, 2020
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Restated Agreement to Repay Individual Loan, by and between Inhibikase Therapeutics Inc. and Milton H. Werner, Ph.D., dated June 13, 2020
Loan Agreements
Inhibikase Therapeutics, Inc.
2020
Second Convertible Revolving Demand Promissory 2019 Note, issued by Inhibikase Therapeutics, Inc. to Joseph Frattaroli, dated December 31, 2019
Note Agreements
Inhibikase Therapeutics, Inc.
2020
Convertible Revolving Demand Promissory Note, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated April 3, 2018
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Form of Late IPO Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2020
Form of Representatives Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
2020
Warrant, issued by Inhibikase Therapeutics, Inc. to Francis E. McDaniel, dated March 31, 2020
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2020
Warrant, issued by Inhibikase Therapeutics, Inc. to Francis E. McDaniel, dated January 1, 2020
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2020
Warrant dated October 5, 2018, issued by Inhibikase Therapeutics, Inc. to Kubera North America, Inc
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2020
Form of Warrant to purchase common stock of the Registrant, issued to each of the investors named in Schedule A thereto
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2020
Form of Underwriting Agreement, including the Form of Lock-Up Agreement
Underwriting Agreements
Inhibikase Therapeutics, Inc.
2020
Specimen common stock Certificate of the Registrant
Stock Agreements
Inhibikase Therapeutics, Inc.
2020
First Amendment to Collaborative Research and Development Agreement, by and between Inhibikase Therapeutics Inc. and Sphaera Pharma Pte. Ltd., dated October 5, 2012
Development Agreements
Inhibikase Therapeutics, Inc.
2020
2011 Equity Incentive Plan and forms of agreements thereunder
Bonus & Incentive Agreements
Inhibikase Therapeutics, Inc.
2020
2020 Equity Incentive Plan
Bonus & Incentive Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2020
Employment Agreement, by and between Inhibikase Therapeutics, Inc. and Milton H. Werner, Ph.D, dated April 1, 2014
Employment Agreements
Inhibikase Therapeutics, Inc.
2020
Employment Agreement, by and between Inhibikase Therapeutics, Inc. and Milton H. Werner Ph.D, to be in effect upon the completion of this offering
Employment Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
MA
2020
Employment Agreement, by and between Inhibikase Therapeutics, Inc. and Joseph Frattaroli, dated October 24, 2018
Employment Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
MA
2020
Form of Inhibikase Therapeutics, Inc. Directors and Officers Indemnification Agreement
Indemnification Agreements
Inhibikase Therapeutics, Inc.
2020
Form of Inhibikase Therapeutics, Inc. Subscription Agreement
Subscription Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Side Letter to Subscription Agreement of Joseph Ventures Allium, LLC, dated July 19, 2018
Subscription Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2020
Side Letter to Subscription Agreement of Joseph Ventures Allium, LLC, dated August 31, 2018
Subscription Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2020
Side Letter to Subscription Agreement of Joseph Ventures Allium, LLC, dated June 15, 2018
Subscription Agreements
Inhibikase Therapeutics, Inc.
2020
Lease Agreement, dated June 5, 2020, by and between Inhibikase Therapeutics, Inc. and Regus Management Group, LLC
Lease Agreements
Inhibikase Therapeutics, Inc.
2020
Form of Consulting Agreement
Consulting Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020